Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Suwon Kyunggi-do
Clinical trial register · South Korea

Clinical Trials in Suwon Kyunggi-do, 2026

Every study on the ClinicalTrials.gov registry that lists a site in South Korea and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3356 matching records held by the registry are in this view. Synced 05 Oct 2026, 03:16 UTC
3356
Studies in scope
all four open statuses
1824
Recruiting now
open to new participants
496
Lead sponsors
across recruiting studies
Top sites
Seoul 2817 Daegu 552 Seongnam-si 489 Busan 469 Goyang-si 396
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
GlaxoSmithKline10
Site location
Seoul2817 Daegu552 Seongnam-si489 Busan469 Goyang-si396
All 252 locations
Target enrolment
to

Trials with a site in Suwon Kyunggi-do

10 of 3356 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in South Korea
Start
Recruiting
A Study to Investigate Velzatinib Compared With Imatinib in Adult Participants With Previously Untreated Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (StrateGIST Frontline)
NCT07585266Gastrointestinal Stromal Neoplasms
GlaxoSmithKline
Phase 3
800
Seoul, Seongnam-si Gyeonggi-do, Suwon Kyunggi-do
2026-07-27
Recruiting
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
NCT07218926Gastrointestinal Neoplasms
GlaxoSmithKline
Phase 3
450
Seoul, Daegu, Seongnam-si Gyeonggi-do, Suwon Kyunggi-do, Yangsan
2025-12-03
Recruiting
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
NCT06716606Connective Tissue Diseases
GlaxoSmithKline
Phase 3
514
Bucheon Kyunggi-Do, Seoul, Suwon Kyunggi-do, Yongsan-Ku Seoul
2024-12-12
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease
NCT06572384Lung Diseases, Interstitial
GlaxoSmithKline
Phase 3
440
Bucheon Kyunggi-Do, Seoul, Suwon Kyunggi-do, Yongsan-Ku Seoul
2024-09-11
Active, closed
Pragmatic Open - Label Randomized Clinical Trial of FF/UMEC/VI vs Non-ellipta Usual Care ICS-LABA for Adult Participants With Uncontrolled Asthma
NCT06372496Asthma
GlaxoSmithKline
Phase 4
1,366
Busan, Daegu, Seongnam-si Gyeonggi-do, Seoul, Suwon Kyunggi-do
2024-04-16
Recruiting
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
NCT05878717Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
GlaxoSmithKline
Phase 2/3
300
Seoul, Suwon Kyunggi-do
2023-09-13
Recruiting
Depemokimab in Participants With Hypereosinophilic Syndrome, Efficacy, and Safety Trial
NCT05334368Hypereosinophilic Syndrome
GlaxoSmithKline
Phase 3
109
Gwangju, Jeonju, Kangwondo, Seoul, Suwon Kyunggi-do
2022-09-06
Active, closed
Efficacy Comparison of Cobolimab + Dostarlimab + Docetaxel to Dostarlimab + Docetaxel to Docetaxel Alone in Participants With Advanced Non-small Cell Lung Cancer Who Have Progressed on Prior Anti-PD-(L)1 Therapy and Chemotherapy
NCT04655976Lung Cancer, Non-Small Cell
GlaxoSmithKline
Phase 2/3
758
Cheongju Chungcheongbuk-do, Daegu, Gyeonggi-do, Pusan, Seongnam-si Gyeonggi-do, Seoul, Suwon Kyunggi-do
2020-12-08
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a South Korean investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 5 October 2026. https://priyalifescience.com/clinical-trials-south-korea/city/suwon-kyunggi-do

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in South Korea and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,356 studies in total at the last sync on 05 Oct 2026, 03:16 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Suwon Kyunggi-do.

How many clinical trials are recruiting in Suwon Kyunggi-do?

7 of the 10 studies on this page are recruiting new participants as of the 05 Oct 2026, 03:16 UTC sync. A further 0 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Suwon Kyunggi-do), 10 studies
PhaseStudiesRecruitingShare
Phase 36660%
Phase 2/32120%
Phase 21010%
Phase 41010%

Most active sponsors

Lead sponsors with the most studies (Suwon Kyunggi-do)
Lead sponsorStudiesRecruiting
GlaxoSmithKline107
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.